SAN ANTONIO, Texas, February 17, 2026--bioAffinity Technologies shares a new case study that demonstrates how CyPath® Lung supports clinical decision-making in high-risk patients.

In a significant advancement for thoracic oncology within the Appalachian region, WVU Medicine has announced it is the first ...

Fortis Hospital Bannerghatta Road has achieved a significant medical milestone by successfully performing Karnataka’s first navigation-based bronchoscopy and lung biopsy, enabling early diagnosis ...

A state-led AI screening drive flags hidden tumours early and sparks national scale-up talks ...

FDA has accepted the NDA for BMS's Iberdomide, an oral agent targetting relapsed/refractory multiple myeloma.

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Ladies and gentlemen, thank you for standing by. My name is Colby, and I will be your conference ...

Q4 2025 earnings call: nsPFA clinical/regulatory timeline, Vybrance rollout, revenue trends, cash burn & outlook—read now.

First in a three-part series. As a laser burned away the hair on her leg, Samar El Hussein felt searing pain. An electrologist at The Refinery Medspa in West Melbourne assured her the work was ...

Background and objectives Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.

Shira Boehler shares her journey being diagnosed with Stage 1 lung cancer. A doctor explains the need for better lung cancer screening for asymptomatic, never smokers.

Colon cancer survivor Vivian Chee has had three lung surgeries since 2021 but continues to keep fit. Read more at straitstimes.com. Read more at straitstimes.com.